María Oneca Agurruza-rekin lankidetzan egindako argitalpenak (4)

2023

  1. Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice

    Diabetologia, Vol. 66, Núm. 11, pp. 2117-2138

  2. Pediococcus acidilactici (pA1c®) alleviates obesity-related dyslipidemia and inflammation in Wistar rats by activating beta-oxidation and modulating the gut microbiota

    Food and Function, Vol. 14, Núm. 24, pp. 10855-10867

  3. Pediococcus acidilactici pA1c® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota

    Pharmaceutics, Vol. 15, Núm. 4

2022

  1. Pediococcus acidilactici CECT9879 (pA1c) Counteracts the Effect of a High‐Glucose Exposure in C. elegans by Affecting the Insulin Signaling Pathway (IIS)

    International Journal of Molecular Sciences, Vol. 23, Núm. 5